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ABSTRACT
Objective: The purpose of this study was to analyze and compare different
valuation methods for population health status measured by the
EuroQol-5D (EQ-5D) in three European countries.
Methods: A representative survey of the noninstitutionalized population
aged 18 and above was conducted in three European countries (Germany,
The Netherlands, and Spain). A total of 11,932 respondents were inter-
viewed using the EQ-5D self-classiﬁer. Health state values based on com-
munity preferences (EQ-5D index) were calculated for each country using
four different value sets: national value sets based on the time trade-off
(TTO) and the visual analogue scale (VAS), the UK TTO-based value set
and the European VAS-based value set. Linear regression analysis was
conducted to evaluate the factors associated with different EQ-5D index
scores depending on the value set used. Loss of quality-adjusted life-years
(QALYs) was calculated for each country using the four value sets by
multiplying the age and gender-speciﬁc values with the respective popula-
tion size.
Results: In all countries, means of all EQ-5D index scores were higher for
men than women, and decreased with age. Index scores calculated using
the national value set based on TTO were higher than those calculated
using the UK TTO-based value set and, also, slightly higher than those
calculated using the European VAS-based value set or the national value
set based on the VAS. The mean loss of QALYs estimated for Germany per
inhabitant varied between 0.062 (national value set based on TTO) and
0.094 (European VAS-based value set). In The Netherlands, the mean loss
of QALYs per inhabitant ranged from 0.090 (national value set based on
TTO) to 0.125 (national value set based on VAS). In Spain, the mean loss
of QALYs per inhabitant ranged between 0.072 (national value set based
on TTO) and 0.085 (European VAS-based value set).
Conclusions: In general, the differences among countries and valuations
were rather small; nevertheless, some important variations should be taken
into account while applying different valuation methods to the EQ-5D
descriptive system. The associations between sociodemographic variables
and health state scores remained the same across countries regardless of
which value sets were used. Using different valuation methods lead to
different QALY losses. To overcome this problem in international surveys
aimed to compare health state scores or QALYs, it is advisable to use a
single valuation method, making these scores comparable.
Keywords: burden of disease, cross-national, EQ-5D, health states.
Introduction
Measures of health-related quality of life (HRQoL) have become
increasingly important in evaluating the outcomes of treatments
or health-care programs. Especially, when establishing priorities
in health care, it is important to measure the likely impact of these
interventions on health status. Preference-based instruments to
measure HRQoL are widely used in cost-utility analysis to inform
health-care priority setting in different countries. In order to
evaluate the different interventions, a common approach has been
used for preference-based measures of health that combine self-
reported health state descriptive systems with a set of preference
weights, usually obtained from the general population (commu-
nity preferences), that are applied to the self-reported data [1].
However, the preference weights used to value the different health
states can be based on different methods. In recent years, it has
been discussed whether these different health state valuation
methods allow for a valid comparisons of health status effects
across different diseases or different populations [2].
The EQ-5D [3] is a simple generic HRQoL questionnaire that
is frequently used for describing and valuing health status. To
health states deﬁned by the EQ-5D descriptive system, various
sets of values based on community preferences (value sets) may
be assigned which have been obtained by various methods in
national and cross-national general population samples (http://
www.euroqol.org).
The purpose of this study was to analyze and compare dif-
ferent value sets for EQ-5D health states of general population
samples of three European countries. We compared the differ-
ences in results regarding the value sets used, as literature sys-
tematically report that different valuation methods yield different
results [4]. Data from the German, Dutch, and Spanish parts of
the European Study of Epidemiology of Mental Disorders
(ESEMeD), a representative household survey in six European
countries, were included in the analysis presented in this study.
The analysis was restricted to these three countries because
various local value sets based on community preferences are only
available in these countries. Countries included had both VAS
and TTO-based value sets available.
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The speciﬁc research questions were:
1. To describe the differences in mean EQ-5D index scores
resulting from using different value sets for EQ-5D health
states.
2. To analyze whether the associations between sociodemo-
graphic factors (gender, education, etc.) and EQ-5D index
scores are different depending on the value set used.
3. To estimate the differences in loss of QALYs resulting from
calculations based on different value sets.
The focus of the analysis was on within-country comparisons.
Cross-country comparisons were only made when using the same
value set (e.g., European VAS) for all countries.
Literature has supported the existence of cultural variations in
values for health states, so it has been recommended to use local
value sets wherever possible [5,6]. However, to our knowledge,
the differences resulting from using different local and cross-
national value sets for EQ-5D health states of general population
samples in various countries have never been analyzed.
Methods
Sample
The ESEMeD project was a cross-sectional household survey
conducted with a sample of individuals representative of the
noninstitutionalized adult (over 18 years of age) population in
six European countries (Belgium, France, Germany, Italy, The
Netherlands, and Spain). A stratiﬁed, multistage, clustered area,
probability sample design was used. Participants were inter-
viewed personally in their homes, using computer-assisted per-
sonal interview techniques. The sample, the objectives of the
study, and the methods used in this study are described in more
detail elsewhere [7,8].
In the subsequent analysis, we only included data from
Germany, The Netherlands, and Spain as these countries are the
only ones that have available VAS and TTO-based local value
sets for EQ-5D health states, calculated from general population
samples. Thus, the total sample used in this article was composed
of 11,392 subjects (3552 in Germany, 2367 in The Netherlands,
and 5473 in Spain). The response rates of these countries were
57.8%, 56.4%, and 78.6%, respectively. The ESEMeD project is
part of the World Health Organization World Mental Health
Survey Initiative [9].
Description of Health States
EQ-5D descriptive system. Health states were described using
the EQ-5D self-report questionnaire. The EQ-5D was developed
by the EuroQoL Group in order to create a standardized
nondisease-speciﬁc instrument for describing and valuing
HRQoL [3]. Respondents have to describe their own health state
on ﬁve dimensions (i.e., mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression). Within each dimension,
there are three levels of severity: 1) no problems; 2) moderate
problems; and 3) severe problems. Thus, the resulting health
state can be deﬁned by a ﬁve-digit code. For instance, state 11123
would indicate no problems in mobility, self-care, and usual
activities, moderate problems in pain/discomfort, and extreme
problems in the dimension anxiety and depression.
Health state valuation methods. Different approaches have been
used for the valuation of EQ-5D health states based on commu-
nity (societal) preferences. For this study, we investigated two
health state valuations. First, we looked at the time trade-off
(TTO) method and second, the visual analogue scale (VAS)
method. Both methods have been used in national surveys across
the three countries included [5,10–13] to derive value sets for
EQ-5D health states. In addition, a European VAS-based value
set [14] and a value set calculated for the UK general population
using the TTO method [15] were used in our analysis. In general,
health state valuation surveys which applied the EQ-5D followed
a similar procedure. Because it was not feasible to value all of the
243 possible health state combinations in these surveys, a
common core of health states (13–45 health states) were valued
directly by the respondents. Following this step, a model of the
directly valuing health states was constructed to interpolate the
valuations of the remaining EQ-5D states.
Time trade-off. The TTO method was developed by Torrance
[16] as an easy-to-adopt valuation method. In general, in this
method, respondents are asked how much of their life expectancy
would they be willing to trade for a shorter life in full health. The
TTO valuation for a given health state Hi is elicited by asking
subjects to consider t time in that state, and then establishing a
(lower) number of years, x, in full health, such that the gain in
health exactly compensates the loss of longevity [17].
Visual analogue scale. The VAS used to value EQ-5D health
states is presented as a vertical thermometer calibrated from zero
(“worst imaginable health sate”) to 100 (“best imaginable health
state”). The task for the respondent is to locate the different
health states on the VAS, i.e., rank ordering the common core of
health states on the VAS. The differences between the positions of
the health states marked on the VAS should correspond to the
differences in preference as perceived by the respondent. The VAS
scores presented in our study were not based on self-reported
VAS data. In our analysis, VAS-based value sets were applied to
the respondents’ self-reported EQ-5D health states. The VAS-
based value sets used in this article were not rescaled to a scale
where zero refers to the state “dead” because only for some of
the VAS-based value sets used in this article, valuations for the
state “dead” were available.
Analysis
Sociodemographic distributions (sex, age, marital status, educa-
tion, employment status, and income in euros per family) are
reported for subjects included. For each of the countries (i.e.,
Germany, The Netherlands, and Spain), we calculated the EQ-5D
index using four different value sets: 1) the national value set
based on the TTO method [11,12,18]; 2) the national value set
based on the VAS method [10,19]; 3) the UK value set based on
the TTO method; and 4) the European value set based on the
VAS method [14]. The German national value sets are based on
two different surveys. The German VAS value set is based on a
national representative sample, whereas the survey conducted to
estimate the TTO value set is based on a regional sample trying
to represent the German population in some socioeconomic vari-
ables (i.e., gender, age). The Spanish and Dutch value sets are
based on single regional surveys, each trying to represent the
national general population.
Because the EQ-5D index scores had skewed distributions,
we used nonparametric methods to analyze this data. Speciﬁcally,
we used the Jackknife method for the estimation of standard
error and conﬁdence intervals (CIs) for parameters. Brieﬂy, the
Jackknife method repeatedly calculates the statistic, each time
omitting just one of the data set’s observations [20,21]. Mean
scores of EQ-5D indexes and 95% CIs were calculated by
country, age group, and gender according to the different value
sets used. Linear regressions were calculated to evaluate the
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factors associated to the different EQ-5D indexes depending on
the value set used by country. Considering the EQ-5D indexes as
dependent variable, gender, age, marital status, employment,
years of education, and mean income were included as indepen-
dent variables. In addition, the loss of QALYs per year were
calculated for each country using the different value sets. To
calculate the loss of QALYs per year, we used the mean country-,
age-, and gender-speciﬁc index scores based on the various value
sets as presented in Table 3. These index scores were subtracted
from 1, which represents the status of perfect health. The result-
ing values, representing the mean loss of QALYs by age and
gender groups in each country, were then multiplied by the
population size in these age and gender groups in each country.
Finally, the resulting QALY losses were summed up for each
country to get the total loss of QALYs (LQALY) per year and
country using the following formula:
LQALY V Ni i
i
n
= −( ) ×[ ]
=
∑ 1
1
(1)
where Vi is the mean EQ-5D index score of age and sex
group i (e.g., men from 18–24 years) and Ni is the population size
(number of people) in the respective age and sex group i.
Estimated proportions and means were weighted to account
for the known probability of selection into the sample as well as to
restore the distribution of the population within each country.
When the Jackknifemethod is used in survey data, primary sample
units (PSU) are omitted instead of observations, N being the
number of PSU instead of the sample size, and the sampling
weights are adjusted as a result of omitting the PSUs. Statistical
analyses were conducted using the Stata Statistical Software 9.0
(StataCorp, College Station, TX), using methods especially de-
signed for analyzing complex sample surveys and weighted data.
Results
Sociodemographic Characteristics
Table 1 depicts the sociodemographic characteristics of the
whole sample and compares the German, Dutch, and Spanish
Table 1 Sociodemographic characteristics of the sample (95% CI)
Total
(N = 11,392)
Germany
(n = 3,552)
The Netherlands
(n = 2,367)
Spain
(n = 5,473)
Gender (%)
Male 48.19 48.23 48.91 47.85
(46.96–49.43) (46.37–50.09) (47.85–52.15) (46.26–49.44)
Female 51.81 51.77 51.09 52.15
(50.57–53.04) (49.91–53.63) (48.47–53.7) (50.56–53.74)
Age (mean, %)
Mean 46.99 47.98 45.26 45.69
(46.54–47.45) (47.31–48.65) (44.32–46.20) (45.01–46.37)
18–24 11.68 9.71 13.51 14.94
(10.81–12.61) (8.50–11.08) (11.31–16.05) (13.65–16.33)
25–34 17.62 16.60 18.47 19.33
(16.70–18.57) (15.26–18.02) (16.58–20.53) (18.03–20.71)
35–49 28.38 29.57 29.10 25.7
(27.30–29.48) (27.95–31.23) (26.86–31.45) (24.27–27.19)
50–64 21.93 23.16 22.02 19.41
(20.93–22.97) (21.67–24.73) (20.07–24.1) (18.04–20.85)
>65 20.39 20.96 16.91 20.62
(19.39–21.43) (19.46–22.54) (15.17–18.80) (19.25–20.06)
Marital status (%)
Married/living with someone 66.23 65.72 71.14 65.34
(65.02–67.42) (63.91–67.49) (68.65–73.51) (63.67–66.98)
Previously married 11.83 13.43 10.93 8.96
(11.03–12.68) (12.19–14.77) (9.69–12.3) (8.10–9.89)
Never married 21.94 20.85 17.93 25.7
(20–88–23.04) (19.32–22.47) (15.75–20.35) (24.11–27.36
Years of education (%)
0–12 years 67.56 74.25 42.71 63.78
(66.38–68.71) (72.58–75.85) (40.2–45.26) (61.83–65.68)
>13 32.44 25.75 57.29 36.22
(31.29–33.62) (24.15–27.42) (54.74–59.8) (34.32–38.17)
Employment (%)
Working (paid employment) 54.88 55.97 61.56 50.08
(53.64–56.12) (54.11–57.81) (59.01–64.04) (48.34–51.83)
Not working 45.12 44.03 38.44 49.92
(43.88–46.36) (42.19–45.89) (35.96–40.99) (48.17–51.66)
Income in euros per year by family (mean, %)
Mean 29,580. 63 33,103.9 41,633. 98 17,754. 21
(28,905.28–30,255.97) (32,070.43–34,137.38) (39,645.13–43,622.83) (17,245.27–18,263.15)
Minimum–P25* within countries 24.02 26.56 22.34 19.56
(22.95–25.13) (24.94–28.24) (20.27–24.55) (18.23–20.95)
P25–P50 within countries 24.77 25.01 21.79 25.44
(23.71–25.85) (23.45–26.64) (16.85–23.87) (23.93–27.01)
P50–P75 within countries 25.21 24.61 26.29 26.01
(24.16–26.30) (23.06–26.24) (24.07–28.64) (24.57–27.5)
P75–maximum within countries 26.00 23.82 29.58 29.00
(24.92–27.1) (22.31–25.39) (27.14–32–13) (27.30–30.76)
*Income groups by percentile of the income in the referring country, minimum to 25 percentile, from 25 percentile to median, from median to 75 percentile, from 75 percentile to maximum.
CI, conﬁdence interval.
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samples. Most of the participants were female (51.81%), with a
mean age of around 47 years, married or living with someone
(66.23%), and with less than 12 years of education (67.56%).
Almost 55% of the whole sample was working and the mean
income in euros per year and family was 29,581.
The three samples were very similar in terms of gender,
although there were signiﬁcant differences (P < 0.001) in age,
marital status, years of education, employment and mean income
per year and family. The German sample was the oldest, with a
mean age of 47.98 years. The Dutch participants showed the
highest frequency in people that are married or living with
someone (71.14%), people with more than 13 years of education
(57.29%), and people with a paid employment (61.56%). On the
other hand, Spain had the lowest mean income per year and
family (€17,754).
Most Frequent Health States
The eight most frequent health states and their index scores in
each of the three countries are summarized in Table 2. The most
frequent health states in all countries are 11111 (no problems in
any dimension) and 11121 (only moderate problems in pain/
discomfort). Spain showed the highest percentage of people that
reported perfect health (73.38%). Summarizing these two health
states showed a cumulative frequency of nearly 80% in all coun-
tries. The following health states (from third to eighth) showed
slightly different patterns across countries. In Germany and
Spain, the same eight most frequent health states are included in
the list, but in a different order, whereas the Dutch list presents
different health states on rank 7 and 8 (22221 and 11211,
respectively). Neither in Germany nor in Spain, these health
states are ranked among the eight most frequent health states.
The TTO-based index scores for health state 11121, which is
the second most frequent health state in all countries, range from
0.887 in Germany, followed by the Spanish TTO-based index
score (0.877), to the Dutch score (0.843). The VAS-based index
scores for the same health state range from 88.0 in Germany,
followed by 79.0 in Spain, to 75.3 in The Netherlands. Greatest
differences for the VAS-based index scores are found for health
state 21221 (78.3 in Germany, 64.5 in Spain, 50.0 in The Neth-
erlands). Greatest differences for the TTO-based index score are
found for health state 11112 ranging from 0.999 in Germany,
followed by 0.910 in Spain, and 0.805 in The Netherlands.
Comparison of Mean EQ-5D Index Scores
Table 3 shows the means of EQ-5D index scores by country, age
group, and gender according to the different value sets used.
Overall, and independently of the country and the method used,
men showed higher (better) mean EQ-5D index scores than
women, and mean EQ-5D index scores decreased with age.
Moreover, mean EQ-5D index scores calculated using the
national value set based on TTO were higher than those calcu-
lated using the UK TTO-based value set and, also, slightly higher
than mean index scores calculated using the European value set
based on the VAS or the national value set based on the VAS.
In the total country samples, the mean TTO-based EQ-5D
national index scores varied between 0.94 (95% CI: 0.93–0.94)
in Germany and 0.91 in The Netherlands (95% CI: 0.90–0.92).
If we look at the data in detail, Spanish and Dutch men between
18 and 24 years had the highest mean TTO-based index scores
(0.98). The national VAS-based index scores range from 93.1 in
Germany, followed by 91.4 in Spain, to 87.4 in The Netherlands.
The lowest scores were found among the oldest group of Spanish
and Dutch women (78.4 and 77.6, respectively) using the
national value set based on VAS. Ta
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Sociodemographic Factors Associated to EQ-5D
Mean Scores
Table 4 shows the different regression models conducted in order
to ascertain the factors associated with EQ-5D index scores
based on the various value sets. The columns show the four
models conducted for each country (i.e., using the national value
set based on TTO, using the national value set based on VAS,
using the European VAS-based value set, and ﬁnally, using the
UK TTO-based value set).
All the regression models showed a statistically signiﬁcant
association between EQ-5D index scores and age: EQ-5D index
scores decreased when age increased. Women showed lower
scores than men in all the models, except in the German model
when the national value set based on TTO was used. Those who
were not working also had statistically signiﬁcant lower scores
than those with paid employment, except in The Netherlands.
In Germany, a positive association between income and the
national EQ-5D index based on TTO was found, but not when
the value set based on VAS was used. With the latter value set,
those who had never been married had lower scores compared
with those married or living with someone.
In The Netherlands, independent of the value set used, the
years of education showed a positive association with the EQ-5D
indexes. In Spain, as in Germany, EQ-5D indexes were higher
among those with the highest income.
Loss of Quality-Adjusted Life-Years in Three
European Countries
Figure 1 shows the loss of QALYs per country inhabitant over 18
years, calculated using the four different valuation methods. The
loss of the QALYs estimated in Germany varied between 0.062
(national value set based on TTO) and 0.094 (European value set
based on VAS). In The Netherlands, the loss of QALYs ranged
from 0.090 (national value set based on TTO) to 0.125 (national
value set based on VAS). Finally, in Spain, the loss of QALYs
ranged between 0.072 (national value set based on TTO) and
0.085 (national value set based on VAS and UK TTO-based value
set).
The loss of QALYs per person using the European value set
based on VAS is highest in The Netherlands (0.102) followed by
Germany (0.094) and Spain (0.080).
Discussion
We have described the HRQoL based on different EQ-5D valu-
ation methods in the general population in Germany, The Neth-
erlands, and Spain. In general, the differences between countries
and valuations are rather small; nevertheless, some important
variations should be taken into account while applying value sets
to the EQ-5D descriptive system.
In accordance with other population surveys, very few health
states accounted for the vast majority of the reported health
states by the respondents in all countries. Eight health states of
the EQ-5D descriptive system summed up to over 90% of the
respondent selections. Almost 70% of the total sample reported
the best possible EQ-5D health state (11111) which is consistent
with other population surveys [18,22,23]. As the value 1 is
assigned to the health state 11111 in all value sets, this resulted
in a very skewed distribution of all EQ-5D index scores and
contributed to the fact that differences in mean EQ-5D index
scores were rather small. Although the large proportion of
respondents reporting the best EQ-5D health state may indicate
very good population health status, it might also be caused by
low sensitivity of the EQ-5D descriptive system. Badia et al.
(1998) have suggested to include a new dimension in the EQ-5D,
well-being, which might be capable to capture variations in
healthy population samples and could therefore be able to
increase the sensitivity of the instrument. In order to increase the
sensitivity and the discriminative ability of the instrument, it has
also been discussed to add more levels to the dimensions to give
the respondent a greater choice in rating their health state
[24,25].
Various population surveys have found an association of
valuation of HRQoL with gender and age [18,26]. In our study,
it could be shown that women have lower EQ-5D index scores
than men regardless of which valuation method was used. This
result applied to all age groups and across all countries. Also, the
age-related decline of mean scores was present for all value sets.
These age and gender associations were signiﬁcant in most of the
regression models applied to the data, i.e., these associations did
not change with the different value sets used. Also, the associa-
tions of EQ-5D index scores with socioeconomic groups (income
and work status) were consistent with other surveys [18,22]. It is
noteworthy that although the average income is lowest in Spain,
the proportion of respondents classifying themselves as having
no health problems (EQ-5D health state 11111) is highest among
the three countries under study. Other surveys have shown that
income is a clear indicator for health status. Because all other
conducted analysis gave no hint for a possible explanation, it
would be necessary to examine this ﬁnding in detail.
The national differences in the estimated mean EQ-5D index
scores were relatively small. Only The Netherlands showed con-
siderable lower EQ-5D index scores than Germany and Spain
regardless of which valuation method was used. This points at a
systematic difference in how Dutch respondents reported prob-
lems on the EQ-5D descriptive system, possibly because of dif-
ferences in health status, in response style, or in the connotation
of response categories in the Dutch language version of the
EQ-5D questionnaire. Although the translation of the EQ-5D
questionnaire followed the ofﬁcial language versions, it could not
be ruled out that the administration of the EQ-5D in different
languages may have caused some of the differences that occurred.
The use of national value sets has been recommended for the
EQ-5D [12]. However, the decision on which value set should be
used is not straightforward. National value sets are often based
on data from regional surveys ([5,10–12,27]). Although these
surveys try to meet the socioeconomic distribution of the
national population, it is still questionable whether these value
sets truly represent the population preference weights. To decide
whether national value sets are superior to a broader European
or a foreign value set, larger representative national surveys
should be carried out with the same estimation procedure to
derive national representative value sets.
Various studies have shown that health state valuations based
on the VAS render lower scores than valuations based on the
TTO method [28]. Yet, both VAS weights and TTO utilities have
frequently been used in health economic evaluation studies. Our
results support these ﬁndings, as value sets based on the TTO
method rendered higher index scores and lower QALY losses
than using VAS-based value sets. Comparison of VAS and TTO-
based EQ-5D index scores may suffer from the fact that anchor-
ing in these valuation methods is different. In VAS-based health
state valuation, the worst imaginable health state is given the
value of 0, whereas in TTO-based valuation, the state “dead” is
given the value of 0. It has been shown in the literature that some
health states may be valued as worse than death which is not
captured in the VAS-based value sets. These differences in
anchoring may have lead to differences in the calculated
mean index scores. To adjust the differences in anchoring of the
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VAS-based and the TTO-based value sets, a rescaling procedure
for the VAS-based value sets is necessary. This was not possible in
our study because only for some of the used VAS-based value
sets, a valuation of the state “dead” is available. To estimate the
impact of rescaling, we have also performed all analyses with the
available rescaled value sets and found only minor differences in
all of the reported results. Analysis with rescaled VAS-based
value sets lead to slightly lower mean scores and higher loss of
QALYs. Therefore, we conclude that our results reported for
VAS-based value sets represent a minor underestimation of
QALY loss (Fig. 1) and overestimation of mean index scores
(Table 3). The associations of the socioeconomic factors with the
VAS-based index scores (Table 4) remained the same when res-
caled value sets were used.
Calculating the loss of QALYs for the population across
countries revealed the biggest differences. Especially in Germany,
applying the national VAS-based and TTO-based value sets to
the data lead to considerable lower loss of QALYs compared
with the loss estimated using the UK TTO-based value set or the
European VAS-based value set. These differences can best be
explained by looking at the construction of the models estimating
the values for the health states. The models used to estimate the
German TTO and VAS-based value set for the different health
states are different from the models used in The Netherlands,
Spain, and the UK, and for the European index. In Germany, the
inﬂuence of health dimensions on the valuations was constructed
without incorporating all problem-related levels of the ﬁve health
dimensions. Usually, the reporting of problems leads to a
decrease in the estimation of the health state valuation. In general
the model is:
V f M , S , U , P , A= ( )i i i i i (2)
where V is the value of a health state and M,S,U,P,A refer to
the ﬁve dimensions (mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression, respectively), i is the level of
each dimension, thus taking a value of 1, 2, or 3 and f() symbolizes
the relationship we are trying to estimate. Reporting a problem is
seen as a decrement in the value of a health state. Valuation studies
in all of the participating countries have estimated a different size
of the decrement used in the equation shown above. Different to
the other value sets, the German value sets have left out some of
the decrements associated with reported problems. In the German
VAS-based value set [10], the moderate level of mobility problems
was given no increment, and in the German TTO-based value set
[11], problems reported in the dimension “usual activities” and
“anxiety and depression” lead to no decrement in the valuation of
these health states. Because in all the other value sets all problems
reported in the ﬁve health dimensions have an impact on the
valuations, this leads to an underestimation of loss of QALYs
using the national TTO and VAS-based value sets in Germany.
This problem also occurs in other health status classiﬁcation
systems such as the Short Form 6-D (SF-6D), where difference in
levels do not result in difference in values [29].
In Germany and The Netherlands, the VAS and TTO value
sets were from different studies which used different samples,
were conducted at different times, and used different statistical
methods to estimate the values for different health states. All this
may have contributed to the differences in mean index scores
reported here. Thus, difference in mean index scores may not
only be because of different valuation methods but also to dif-
ferences in sample characteristics. In Spain, the VAS and TTO
value sets are from identical studies.
Limitations
The mode of data collection in the surveys conducted here was
face-to-face interviews. Usually, EQ-5D surveys were conducted
using mail surveys. Self-administered questionnaires mailed to
respondents generally yield higher levels of reporting of sensitive
behavior than questions administered by face-to-face interviews.
Although the questionnaire asks mainly about physical health, it
is possible that the question about mental health (anxiety/
depression) may be regarded as sensitive. This might have led to
an underreporting of problems in some of the dimensions
described by the EQ-5D.
Furthermore, the value sets for EQ-5D health states com-
pared in this study are based on general populations surveys
conducted at different times prior to the ESEMeD survey. As
preference for health states may change over time, this causes a
further limitation of our study. In addition, the studies differed
with regard to the used sample size and the analytical methods
used to derive the value sets which may limit the generalizability
of the presented results.
Conclusions
Using the existing national value sets for calculating loss of
QALYs may lead to different results merely because the value set
used is based on a different calculation method. Irrespective of
the used value set, it is noteworthy that a considerable amount of
QALYs are lost in the three countries. Applying VAS-based index
scores to the data gives lower health state scores than applying
TTO-based scores. Therefore, to compare health state scores or
loss of QALYs across countries, it is advisable to use a single
value set, such as the European VAS-based value set or the UK
TTO value set. To overcome the aforementioned problem and to
obtain more reliable national value sets, it is advisable to conduct
bigger national representative surveys, such as the UK survey, to
derive national value sets. To calculate these value sets and to
make them comparable across countries, it is necessary to use the
same calculation model in all surveys, because different valuation
methods yield different results. Up to date, in international
surveys conducted to compare health state scores across coun-
tries, it is recommended to apply a single value set, such as the
UK value set, to data sets. Otherwise, the model used to derive
value sets may distort the results and these false premises may
lead to burden calculations or health priority settings that are not
justiﬁed. As expected and reported in other surveys, health state
scores decreased with age and are higher in men than in women
in all of the analyzed countries. These associations remain the
same across countries regardless of which EQ-5D index scores
were used.
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Figure 1 Estimated loss of quality-adjusted life-years per year and inhabitant
using different valuation methods.TTO, time trade-off;VAS, visual analogue scale.
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